Home

Bioworkshops sell "Pembrolizumab"

Basic Information

790
36
8
3.8(21)

Trade Type

Sell

Product Name

Pembrolizumab

Manufacturer(s)

Specifications

  • Expression System: Developed from a DMF-filed mammalian cell line optimized for consistently high titer and cost-efficient large-scale manufacturing
  • Regulatory Status: Reference product originally approved by the US FDA in September 2014 (Merck); biosimilar cell line developed with proven analytical comparability for global regulatory readiness
  • Application: Anti-PD-1 monoclonal antibody cell-line platform used in oncology, with melanoma as a representative indication

Documents

GMP
Filters:
Sort by:

    No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Similar Products & Services

Products & Services related to what you're viewing

People Also Viewed

Other products & services viewed by people who looked at this product